Chemoinformaics analysis of 4-[3-(4-Hydroxyphenyl)propyl]-3-methoxyphenol
| Molecular Weight | 258.317 | nRot | 5 |
| Heavy Atom Molecular Weight | 240.173 | nRig | 12 |
| Exact Molecular Weight | 258.126 | nRing | 2 |
| Solubility: LogS | -3.202 | nHRing | 0 |
| Solubility: LogP | 3.382 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 2 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 12 |
| nHA | 3 | APOL | 41.1283 |
| nHD | 2 | BPOL | 19.7937 |
| QED | 0.865 |
| Synth | 1.851 |
| Natural Product Likeliness | 0.565 |
| NR-PPAR-gamma | 0.052 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.05 |
| Pgp-sub | 0.006 |
| HIA | 0.006 |
| CACO-2 | -4.78 |
| MDCK | 0.0000176 |
| BBB | 0.06 |
| PPB | 0.965112 |
| VDSS | 1.158 |
| FU | 0.0239863 |
| CYP1A2-inh | 0.985 |
| CYP1A2-sub | 0.915 |
| CYP2c19-inh | 0.965 |
| CYP2c19-sub | 0.144 |
| CYP2c9-inh | 0.841 |
| CYP2c9-sub | 0.962 |
| CYP2d6-inh | 0.969 |
| CYP2d6-sub | 0.926 |
| CYP3a4-inh | 0.716 |
| CYP3a4-sub | 0.432 |
| CL | 12.999 |
| T12 | 0.883 |
| hERG | 0.134 |
| Ames | 0.092 |
| ROA | 0.107 |
| SkinSen | 0.946 |
| Carcinogencity | 0.19 |
| EI | 0.98 |
| Respiratory | 0.213 |
| NR-Aromatase | 0.746 |
| Antiviral | No |
| Prediction | 0.639092 |